- Home
- DUOL vs ASND Comparison
DUOL vs ASND Comparison
Compare DUOL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUOL
- ASND
- Stock Information
- Founded
- DUOL 2011
- ASND 2006
- Country
- DUOL United States
- ASND Denmark
- Employees
- DUOL N/A
- ASND N/A
- Industry
- DUOL Computer Software: Prepackaged Software
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- DUOL Technology
- ASND Health Care
- Exchange
- DUOL Nasdaq
- ASND Nasdaq
- Market Cap
- DUOL 23.9B
- ASND 10.6B
- IPO Year
- DUOL 2021
- ASND 2015
- Fundamental
- Price
- DUOL $401.00
- ASND $171.48
- Analyst Decision
- DUOL Buy
- ASND Strong Buy
- Analyst Count
- DUOL 15
- ASND 16
- Target Price
- DUOL $453.31
- ASND $218.19
- AVG Volume (30 Days)
- DUOL 943.5K
- ASND 398.5K
- Earning Date
- DUOL 08-06-2025
- ASND 05-01-2025
- Dividend Yield
- DUOL N/A
- ASND N/A
- EPS Growth
- DUOL 114.70
- ASND N/A
- EPS
- DUOL 2.04
- ASND N/A
- Revenue
- DUOL $811,214,000.00
- ASND $398,509,511.00
- Revenue This Year
- DUOL $35.96
- ASND $75.05
- Revenue Next Year
- DUOL $26.84
- ASND $78.14
- P/E Ratio
- DUOL $197.92
- ASND N/A
- Revenue Growth
- DUOL 39.15
- ASND 12.06
- 52 Week Low
- DUOL $145.05
- ASND $111.09
- 52 Week High
- DUOL $544.93
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- DUOL 30.39
- ASND 53.96
- Support Level
- DUOL $383.60
- ASND $166.84
- Resistance Level
- DUOL $426.80
- ASND $180.78
- Average True Range (ATR)
- DUOL 19.47
- ASND 5.63
- MACD
- DUOL -9.49
- ASND -0.64
- Stochastic Oscillator
- DUOL 24.96
- ASND 47.35
About DUOL Duolingo Inc.
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.